Niva Bupa Health Insurance IPO Hits Indian Market, Receive Positive Response from Investors
The initial public offering (IPO) of Niva Bupa Health Insurance Limited made its debut in the Indian primary market on November 7, 2024, and has been oversubscribed by investors.
The public issue, which is set to close on November 11, 2024, has seen a strong response from retail, non-retail investors (NII) segments. According to Niva Bupa Health Insurance IPO subscription status, the public issue has been subscribed to 1.17 times in the first two days of bidding.
In the grey market, shares have continued to trade positively, with a Grey Market Premium (GMP) of ₹5 per share, unchanged from the weekend.
"The book build issue has seen a strong response, with the retail portion receiving an enthusiastic response," said analysts at Canara Bank Securities. "The diversified channel mix, which includes corporate agents, individual agents, and broker channels, is expected to contribute positively to the company's growth."
Niva Bupa Health Insurance IPO Review by analysts:
- Bajaj Capital has assigned a 'subscribe for long term' tag and highlighted the following financial performance indicators: ₹2809.97 crore gross written premium / net profit of ₹-196.53 crore (FY22), and ₹5607.57 crore/ ₹81.85 crore (FY24).
- Canara Bank Securities also gave a strong endorsement to the IPO, stating that the company has a diversified channel mix with individual agents contributing significantly to their business.
Niva Bupa Health Insurance IPO Subscription Details:
- Public Issue Subscribed 1.17 times
- Retail Portion 1.34 Times
- NII Segment 0.40 Times
- QIB Segment 1.50 Times
Investors are advised to exercise caution and carefully evaluate the market trends before making any investment decisions.
The final update on the IPO offer will be available after midnight on November 11, 2024.